CLS’s acting CEO Dan J. Mogren returns to work after medical leave
Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announced that the company’s acting CEO Dan J. Mogren returns to work from April 1st, after a planned medical leave from February 10th until March 31st.“I underwent a routine heart valve replacement procedure that required some weeks of recovery. The surgery and recovery have gone very well, and I look forward to coming back to work in full power”, said Dan J. Mogren, acting CEO of CLS. Dan J. Mogren replaces deputy CEO Lars-Erik Eriksson, who will continue his role as CFO. Contact Information:Dan J.